FDA CDER Draft Process Validation Guidance Rev.

FDA Center for Drugs (CDER), Center for Biologics (CBER) and Center for Vetinary Medicine released a a draft revision to its old 1987 Process Validation gudiance. This guidance is entitled: “Process Validation: General Principles and Practices”.

The revisions include significant flexibllity including use of process design information (even if not performed under cGMPs) to support process validation conclusions) and they define 2 basic stages for Process Validation: Stage 1 – Process Design and Stage 2 Process Qualifications. Stage 2 includes qualification of Utilities and Equipment and Performance Qualification.

Cybersecurity Review

Our cybersecurity experts are NESSUS Pro Licensed and can quickly remediate cybersecurity deficiencies with your medical device or digital health software.  Planning, requirements, validation, and submissions – we can assist with all.

Interested in having a conversation?  Email us to arrange a Zoom meeting or call us at +1 781-721-2921.


Corporate Office

15148 Springview St
Tampa, FL 33624
Partners located in the US (CA, FL, MA, MN), Canada, and Italy.